PRESS RELEASE published on 05/06/2024 at 23:25, 2 years 3 months ago Jolt Health To Acquire HCQ Transdermal Patch Technology Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027* Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF published on 03/27/2024 at 21:55, 2 years 4 months ago Jolt Health Inc. annonce la clôture du financement Financement Placement Privé Remboursement De Dette Jolt Santé Inc. Fonds De Roulement
BRIEF published on 03/27/2024 at 21:55, 2 years 4 months ago Jolt Health Inc. Announces Closing of Financing Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE published on 03/27/2024 at 21:50, 2 years 4 months ago Jolt Health Inc. Announces Closing of Financing Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.
BRIEF published on 03/08/2024 at 13:05, 2 years 5 months ago Jolt Health Inc. annonce des expansions stratégiques et des changements au conseil d'administration Santé Et Bien-être Médicaments Jolt Santé Inc. Développement De Médicaments IA Financement Par Placement Privé
BRIEF published on 03/08/2024 at 13:05, 2 years 5 months ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 2 years 5 months ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 3 years 5 months ago Love Pharma Inc. Announces Share Consolidation
Published on 08/07/2026 at 23:15, 2 days 2 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 2 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 3 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 3 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 00:05, 1 hour 52 minutes ago Games of the Future Astana 2026 Comes to a Close After 12 Electric Days of Competition
Published on 08/09/2026 at 15:05, 10 hours 52 minutes ago GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/08/2026 at 16:25, 1 day 9 hours ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 2 days 2 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 7 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 2 days 7 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 2 days 7 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
